Verquvo (vericiguat)
pCPA File Number:
22399
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or intravenous diuretic therapy
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
SR0758
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable